Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05669508 · ClinicalTrials.gov registry record · NA
Wearable Electrical Stimulation on the Back to Modulate Spinal Cord Activity
A NA study of Spinal Cord Injuries and Spinal Cord Diseases, sponsored by Thomas Jefferson University.
- Active
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT05669508: Active NA study of Spinal Cord Injuries and Spinal Cord Diseases, sponsored by Thomas Jefferson University.
NCT05669508 is a NA study of Spinal Cord Injuries and Spinal Cord Diseases that is active but no longer recruiting, run by Thomas Jefferson University. The registered enrollment target is 4 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05669508, a NA study of Spinal Cord Injuries and Spinal Cord Diseases, is active but no longer recruiting, sponsored by Thomas Jefferson University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate if non-invasive electrical spinal stimulation can help people with paralysis caused by SCI improve strength and function of their arms, legs, hands or feet. The study will involve therapy sessions involving exercises done at the same time as electrical stimulation therapy. This study has multiple parts to evaluate the effectiveness and safety of "smart" electrical stimulation of the spinal cord, which involves stimulating the spinal cord at precise locations and times to improve movement and function.
Primary Outcome
Standard neurological assessment for determining level and severity of impairment after spinal cord injury. It includes a sensory exam (dermatological light touch and pin prick) and motor exam (manual muscle strength testing).
Conditions Studied
Interventions
- DEVICE RISES-T System
- OTHER Occupational/Physical Therapy
Study Locations (1)
Pennsylvania
- Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2022-02-10 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT05669508 still lists
NCT05669508 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which RISES-T System is the first listed.
NCT05669508 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05669508 about?
NCT05669508 is a clinical study titled "Wearable Electrical Stimulation on the Back to Modulate Spinal Cord Activity". The goal of this study is to evaluate if non-invasive electrical spinal stimulation can help people with paralysis caused by SCI improve strength and function of their arms, legs, hands or feet. The study will involve therapy sessions involving exercises done at the same time as electrical stimulati...
What is the current status of trial NCT05669508?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 4 participants. The study started on 2022-02-10. Estimated completion is 2026-12-31.
What conditions does trial NCT05669508 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Spinal Cord Diseases.
What interventions are being tested in trial NCT05669508?
The interventions under investigation include: RISES-T System (DEVICE), Occupational/Physical Therapy (OTHER).
Who is sponsoring clinical trial NCT05669508?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05669508 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05669508's enrollment target sits among peer trials
4 196th of 202 higher than 4 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy